DETERMINATION OF MULTIDRUG RESISTANCE LEVEL IN K562 LEUKEMIA CELLS BY 3D-ELECTRODE CONTACTLESS DIELECTROPHORESIS

被引:0
|
作者
Demircan, Y. [1 ,2 ]
Erdem, M. [3 ]
Ozgur, E. [2 ]
Gunduz, U. [3 ]
Kulah, H. [1 ,2 ]
机构
[1] METU, Dept Elect & Elect Engn, Ankara, Turkey
[2] METU MEMS Ctr, Ankara, Turkey
[3] METU, Dept Biol, Ankara, Turkey
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
In this study, 3D-electrode contactless dielectrophoresis (DEP) system is utilized to drive a relationship between the drug resistance level and dielectrophoretic response of doxorubicin resistant K562 (K562/dox) cells. The number of trapped cells, stained fluorescently, is ascertained by measuring the light intensity with Image J. For accurate counting of cells through intensity analysis, an algorithm was developed, which exploits cell transparency. K562/dox cells resistant to 100, 300, 500 and 1000 nM doxorubicin are used for the analysis. A significant increase in trapped cell number is observed up to 300 nM. However, further increase in drug resistance level is not reflected in DEP response, considerably.
引用
收藏
页码:837 / 840
页数:4
相关论文
共 50 条
  • [1] Label-free detection of multidrug resistance in K562 cells through isolated 3D-electrode dielectrophoresis
    Demircan, Yagmur
    Koyuncuoglu, Aziz
    Erdem, Murat
    Ozgur, Ebru
    Gunduz, Ufuk
    Kulah, Haluk
    ELECTROPHORESIS, 2015, 36 (9-10) : 1149 - 1157
  • [2] Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
    Wang, Yu Jia
    Zhao, Huan Dong
    Zhu, Cai Feng
    Li, Jian
    Xie, Hong Juan
    Chen, Yu Xiang
    JOURNAL OF CANCER, 2017, 8 (06): : 1103 - 1112
  • [3] Effects of Iron Deprivation on Multidrug Resistance of Leukemic K562 Cells
    Fang, Dingzhu
    Bao, Yixiao
    Li, Xiaobin
    Liu, Fang
    Cai, Kang
    Gao, Ju
    Liao, Qingkui
    CHEMOTHERAPY, 2010, 56 (01) : 9 - 16
  • [4] Experimental study of reversal of multidrug resistance in human leukemia K562/DOX cells by toad venom
    Hu Pei
    Qiu Zhichao
    Li Yaohe
    Liu Anping
    Chen Zhixiong
    Huliwen
    Luo Man
    Guxuekui
    Xiaoyang
    Xie Ying
    Hai, Lan
    ADVANCES IN NANO RESEARCH, 2021, 11 (02) : 219 - 225
  • [5] Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02
    Arken, Nurguli
    CELLULAR AND MOLECULAR BIOLOGY, 2019, 65 (01) : 78 - 83
  • [6] Upregulation of stem cell genes in multidrug resistant K562 leukemia cells
    Lehne, Gustav
    Grasmo-Wendler, Unn-Hilde
    Berner, Jeanne-Marie
    Meza-Zepeda, Leonardo A.
    Adamsen, Birgitte Lid
    Flack, Aksel
    Reiner, Andrew
    Clausen, Ole Petter Fraas
    Hovig, Eivind
    Myklebost, Ola
    LEUKEMIA RESEARCH, 2009, 33 (10) : 1379 - 1385
  • [7] Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist
    Miyake, N
    Fujita, R
    Ishikawa, M
    Takayanagi, M
    Takayanagi, Y
    Sasaki, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 82 (03): : 265 - 268
  • [8] Imatinib resistance in multidrug-resistant K562 human leukemic cells
    Assef, Yanina
    Rubio, Fernanda
    Colo, Georgina
    del Monaco, Silvana
    Costas, Monica A.
    Kotsias, Basilio A.
    LEUKEMIA RESEARCH, 2009, 33 (05) : 710 - 716
  • [9] Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin
    Yalcintepe, Leman
    Halis, Emre
    Ulku, Sibel
    ONCOLOGY LETTERS, 2016, 11 (03) : 2290 - 2296
  • [10] Comparison of antileukemic immunity mediated by dendritic cells derived from multidrug resistant leukemia K562/A02 cells and sensitive K562 cells
    Zhang, YM
    Zhang, LS
    Zhang, YF
    Chai, Y
    Yi, LC
    Song, FX
    CHINESE MEDICAL JOURNAL, 2005, 118 (07) : 595 - 597